S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SLRX Salarius Pharmaceuticals Inc

1.68

-0.16 (-8.70%)

After Hours

Last Updated: 09:04:16

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Salarius Pharmaceuticals Charts.

Salarius Pharmaceuticals (NASDAQ:SLRX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Salarius Pharmaceuticals Charts.

Salarius Pharmaceuticals Inc News

Form EFFECT - Notice of Effectiveness
Monday 30 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 24 December 2024 (1 week ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 16 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Saturday 2 November 2024 (2 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Saturday 2 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 28 September 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 16 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 15 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 10 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 26 July 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 26 July 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 23 July 2024 (5 months ago) • Edgar (US Regulatory)

More Salarius Pharmaceuticals Inc News Articles

Alpha Quark Token

PÃO DE AÇUCAR ON

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions